3060 Journal of Medicinal Chemistry, 2008, Vol. 51, No. 11
Letters
(9) Tu, H.; Rondard, P.; Xu, C.; Bertaso, F.; Cao, F.; Zhang, X.; J.; Pin,
J.-P.; Liu, J. Dominant role of GABAB 2 and Gꢀγ for GABAB
receptor-mediated-ERK1/2/CREB pathway in cerebellar neurons. Cell.
Signalling 2007, 19, 1996–2002.
(10) Pin, J.-P.; Kniazeff, J.; Binet, V.; Liu, J.; Maurel, D.; Galvez, T.;
Duthey, B.; Havlickova, M.; Blahos, J.; Pre´zeau, L.; Rondard, P.
Activation mechanism of the heterodimeric GABAB receptor. Bio-
chem. Pharmacol. 2004, 68, 1565–1572.
(11) Galvez, T.; Duthey, B.; Kniazeff, J.; Blahos, J.; Rovelli, G.; Bettler,
B.; Pre´zeau, L.; Pin, J.-P. Allosteric interactions between GB1 and
GB2 subunits are required for optimal GABAB receptor function.
EMBO J. 2001, 20, 2152–2159.
(12) Pagano, A.; Rovelli, G.; Mosbacher, J.; Lohmann, T.; Duthey, B.;
Stauffer, D.; Ristig, D.; Schuler, V.; Meigel, I.; Lampert, C.; Stein,
T.; Pre´zeau, L.; Blahos, J.; Pin, J.-P.; Froestl, W.; Kuhn, R.; Heid, J.;
Kaupmann, K.; Bettler, B. C-Terminal interaction is essential for
surface trafficking but not for heteromeric assembly of GABAB
receptors. J. Neurosci. 2001, 21, 1189–1202.
(13) Kniazeff, J.; Galvez, T.; Labesse, G.; Pin, J.-P. No ligand binding in
the GB2 subunit of the GABAB receptor is required for activation
and allosteric interaction between the subunits. J. Neurosci. 2002, 22,
7352–7361.
(14) Liu, J.; Maurel, D.; Etzol, S.; Brabet, I.; Ansanay, H.; Pin, J.-P.;
Rondard, P. Molecular determinants involved in the allosteric control
of agonist affinity in the GABAB receptor by the GABAB2 subunit.
J. Biol. Chem. 2004, 279, 15824–15830.
(15) (a) Kozikowski, A. P.; Kotoula, M.; Ma, D.; Boujrad, N.; Tuc¨kmantel,
W.; Papadopoulos, V. Synthesis and biology of a 7-nitro-2,1,3-
benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluo-
rescent probe for the peripheral-type benzodiazepine receptor. J. Med.
Chem. 1997, 40, 2435–2439. (b) Taliani, S.; Simorini, F.; Sergianni,
V.; La Motta, C.; Da Settimo, F.; Cosimelli, B.; Abignente, E.; Greco,
G.; Novellino, E.; Rossi, L.; Gremigni, V.; Spinetti, F.; Chelli, B.;
Martini, C. New fluorescent 2-phenylindolglyoxylamide derivatives
as probes targeting the peripheral-type benzodiazepine receptor: design,
synthesis, and biological evaluation. J. Med. Chem. 2007, 50, 404–
407. (c) Cha, J. H.; Zou, M. F.; Adkins, E. M.; Rasmussen, S. G. F.;
Loland, C. J.; Schoenenberger, B.; Gether, U.; Newman, A. H.
Rhodamine-labeled 2ꢀ-carbomethoxy-3ꢀ-(3,4-dichlorophenyl) tropane
analogues as high-affinity fluorescent probes for the dopamine
transporter. J. Med. Chem. 2005, 48, 7513–7516.
96, 14694–14699. (b) Adam, G. C.; Cravatt, B. F.; Sorensen, E. J.
Proteomic profiling of mechanistically distinct enzyme classes using
a common chemotype. Nat. Biotechnol. 2002, 20, 805–809. (c)
Saghatelian, A.; Jessani, N.; Joseph, A.; Humphrey, M.; Cravatt, B. F.
Activity-based probes for the proteomic profiling of metalloproteases.
Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 10000–10005.
(18) Kaupmann, K.; Huggel, K.; Heid, J.; Flor, P. J.; Bischoff, S.; Mickel,
S. J.; McMaster, G.; Angst, C.; Bittiger, H. Expression cloning of
GABAB receptors uncovers similarity to metabotropic glutamate
receptors. Nature 1997, 386, 239–246.
(19) Hatanaka, Y.; Sadakane, Y. Photoaffinity labeling in drug discovery
and developments: chemical gateway for entering proteomic frontier.
Curr. Top. Med. Chem. 2002, 2, 271–288.
(20) Karolin, J.; Johansson, L. B. A.; Strandberg, L.; Ny, T. Fluorescence
and absorption spectroscopic properties of dipyrrometheneboron
difluoride (BODIPY) derivatives in liquids, lipid membranes, and
proteins. J. Am. Chem. Soc. 1994, 116, 7801–7806.
(21) Belley, M.; Sullivan, R.; Reeves, A.; Evans, J.; O’Neill, G.; Ng,
G. Y. K. Synthesis of the nanomolar photoaffinity GABAB receptor
ligand CGP 71872 reveals diversity in the tissue distribution of
GABAB receptor forms. Bioorg. Med. Chem. 1999, 7, 2697–2704.
(22) Li, Z. G.; Mintzer, E.; Bittman, R. First synthesis of free cholesterol-
BODIPY conjugates. J. Org. Chem. 2006, 71, 1718–1721.
(23) Hatanaka, Y.; Hashimoto, M.; Kurihara, H.; Nakayama, H.; Kanaoka,
Y. A novel family of aromatic diazirines for photoaffinity labeling. J.
Org. Chem. 1994, 59, 383–387.
(24) Kolb, H. C.; Sharpless, K. B. The growing impact of click chemistry
on drug discovery. Drug DiscoVery Today 2003, 8, 1128–1137.
(25) Schneckenburger, H. Total internal reflection fluorescence microscopy:
technical innovations and novel applications. Curr. Opin. Biotechnol.
2005, 16, 13–18.
(26) Gross, L. A.; Baird, G. S.; Hoffman, R. C.; Baldridge, K. K.; Tsien,
R. Y. The structure of the chromophore within DsRed, a red fluorescent
protein from coral. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 11990–
11995.
(27) (a) Shreder, K. R.; Wong, M. S.; Nomanbhoy, T.; Leventhal, P. S.;
Fuller, S. R. Synthesis of AX7593, a quinazoline-derived photoaffinity
probe for EGFR. Org. Lett. 2004, 6, 3715–3718. (b) Zoffmann, S.;
Turcatti, G.; Galzi, J. L.; Dahl, M.; Chollet, A. Synthesis and
characterization of fluorescent and photoactivatable MIP-1R ligands
and interactions with chemokine receptors CCR1 and CCR5. J. Med.
Chem. 2001, 44, 215–222.
(16) Evans, M. J.; Cravatt, B. F. Mechanism-based profiling of enzyme
families. Chem. ReV. 2006, 106, 3279–3301.
(17) (a) Liu, Y.; Patricelli, M. P.; Cravatt, B. F. Activity-based protein
profiling: the serine hydrolases. Proc. Natl. Acad. Sci. U.S.A. 1999,
JM800140F